drugset / Trial / NCT01621737
Antipsychotic Effects of Oxytocin
Terminated
42 enrolled
University of California, San Diego
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve symptoms in schizophrenia patients who have residual symptoms despite being on adequate treatment with antipsychotic medication.
Timeline
- Start
- 2011-06
- Primary completion
- 2018-12
- Completion
- 2018-12
Outcome
Outcome not reported
Stopped (Business): “Break in funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 42 iu | Intranasal |
| Subject | Oxytocin | Peptide | 84 iu | Intranasal |